Organic Letters
Letter
Mellor, M.; Swain, M. L.; Tucker, J. A. Bioorg. Med. Chem. Lett. 2009,
19, 6670−6674. (c) Golub, A. G.; Bdzhola, V. G.; Briukhovetska, N.
V.; Balanda, A. O.; Kukharenko, O. P.; Kotey, I. M.; Ostrynska, O. V.;
Yarmoluk, S. M. Eur. J. Med. Chem. 2011, 46, 870−876.
(d) McClellan, W. J.; Dai, Y.; Abad-Zapatero, C.; Albert, D. H.;
Bouska, J. J.; Glaser, K. B.; Magoc, T. J.; Marcotte, P. A.; Osterling, D.
J.; Stewart, K. D.; Davidsen, S. K.; Michaelides, M. R. Bioorg. Med.
Chem. Lett. 2011, 21, 5620−5624. (e) Bugge, S.; Kaspersen, S. J.;
Larsen, S.; Nonstad, U.; Bjørkøy, G.; Sundby, E.; Hoff, B. H. Eur. J.
Med. Chem. 2014, 75, 354−374. (f) Gryshchenko, A. A.; Bdzhola, V.
G.; Balanda, A. O.; Briukhovetska, N. V.; Kotey, I. M.; Golub, A. G.;
Ruban, T. P.; Lukash, L. L.; Yarmoluk, S. M. Bioorg. Med. Chem. 2015,
23, 2287−2293. (g) El-Ansary, A. K.; Kamal, A. M.; Al-Ghorafi, M. A.
Chem. Pharm. Bull. 2016, 64, 1172−1180. (h) Bugge, S.; Buene, A. F.;
Jurisch-Yaksi, N.; Moen, I. U.; Skjønsfjell, E. M.; Sundby, E.; Hoff, B.
H. Eur. J. Med. Chem. 2016, 107, 255−274. (i) Ostrynska, O. V.;
Balanda, A. O.; Bdzhola, V. G.; Golub, A. G.; Kotey, I. M.;
Kukharenko, O. P.; Gryshchenko, A. A.; Briukhovetska, N. V.;
Yarmoluk, S. M. Eur. J. Med. Chem. 2016, 115, 148−160.
(14) Campos, J. F.; Queiroz, M.-J. R. P.; Berteina-Raboin, S.
Catalysts 2018, 8, 137−150.
(15) (a) Salamoun, J. M.; McQueeney, K. E.; Patil, K.; Geib, S. J.;
Sharlow, E. R.; Lazo, J. S.; Wipf, P. Org. Biomol. Chem. 2016, 14,
6398−6402. (b) Cai, J.; Huang, S.; He, R.; Chen, L.; Chen, D.; Jiang,
S.; Li, B.; Li, Y. Org. Biomol. Chem. 2017, 15, 333−337.
(16) (a) Oshima, T.; Yamanaka, I.; Kumar, A.; Yamaguchi, J.;
Nishiwaki-Ohkawa, T.; Muto, K.; Kawamura, R.; Hirota, T.; Yagita,
K.; Irle, S.; Kay, S. A.; Yoshimura, T.; Itami, K. Angew. Chem., Int. Ed.
2015, 54, 7193−7197. (b) Ziadi, A.; Uchida, N.; Kato, H.; Hisamatsu,
R.; Sato, A.; Hagihara, S.; Itami, K.; Torii, K. U. Chem. Commun.
2017, 53, 9632−9635. (c) Kitano, H.; Choi, J.-H.; Ueda, A.; Ito, H.;
Hagihara, S.; Kan, T.; Kawagishi, H.; Itami, K. Org. Lett. 2018, 20,
5684−5687.
(4) The collaboration work with the group of Torii (ITbM and
University of Texas, Austin) on the biological study of thieno[2,3-d]
pyrimidine toward the plant stomata development will be reported in
due course. For reviews and a recent study on the plant stomata
development, see: (a) Han, S.-K.; Torii, K. U. Development 2016, 143,
1259−1270. (b) Pillitteri, L. J.; Torii, K. U. Annu. Rev. Plant Biol.
2012, 63, 591−614. (c) Putarjunan, A.; Ruble, J.; Srivastava, A.; Zhao,
C.; Rychel, A. L.; Hofstetter, A. K.; Tang, X.; Zhu, J.-K.; Tama, F.;
Zheng, N.; Torii, K. U. Nature Plants 2019, 5, 742−754.
(5) Bugge, S.; Kaspersen, S. J.; Sundby, E.; Hoff, B. H. Tetrahedron
2012, 68, 9226−9233.
(6) For selected α-selective arylation of benzo[b]thiophene, see:
(a) Yanagisawa, S.; Sudo, T.; Noyori, R.; Itami, K. J. Am. Chem. Soc.
2006, 128, 11748−11749. (b) Join, B.; Yamamoto, T.; Itami, K.
́
Angew. Chem., Int. Ed. 2009, 48, 3644−3647. (c) Liegault, B.;
Lapointe, D.; Caron, L.; Vlassova, A.; Fagnou, K. J. Org. Chem. 2009,
́
74, 1826−1834. (d) Colletto, C.; Panigrahi, A.; Fernandez-Casado, J.;
Larrosa, I. J. Am. Chem. Soc. 2018, 140, 9638−9643. Seminal work
reported by Ohta et al., see: (e) Ohta, A.; Akita, Y.; Ohkuwa, T.;
Chiba, M.; Fukunaga, R.; Miyafuji, A.; Nakata, T.; Tani, N.; Aoyagi, Y.
Heterocycles 1990, 31, 1951−1958.
(7) For selected β-selective arylation of benzo[b]thiophene, see:
(a) Ueda, K.; Yanagisawa, S.; Yamaguchi, J.; Itami, K. Angew. Chem.,
Int. Ed. 2010, 49, 8946−8949. (b) Kirchberg, S.; Tani, S.; Ueda, K.;
Yamaguchi, J.; Studer, A.; Itami, K. Angew. Chem., Int. Ed. 2011, 50,
2387−2391. (c) Tang, D.-T. D.; Collins, K. D.; Glorius, F. J. Am.
́
Chem. Soc. 2013, 135, 7450−7453. (d) Colletto, C.; Islam, S.; Julia-
́
Hernandez, F.; Larrosa, I. J. Am. Chem. Soc. 2016, 138, 1677−1683.
(8) (a) Murakami, K.; Yamada, S.; Kaneda, T.; Itami, K. Chem. Rev.
2017, 117, 9302−9332. (b) Das, R.; Kapur, M. Asian J. Org. Chem.
2018, 7, 1217−1235.
(9) H/D exchange experiments toward 1a supported the Ag(I)-
mediated C−H activation pathway rather than the palladium C−H
́
mediated C−H activation pathway, see ref 6d, (a) Mudarra, A. L.;
Martínez de Salinas, S.; Perez-Temprano, M. H. Org. Biomol. Chem.
́
2019, 17, 1655−1667. and references therein. For palladium-
catalyzed C−H activation mechanism, see (b) Davies, D. L.;
Macgregor, S. A.; McMullin, C. L. Chem. Rev. 2017, 117, 8649−
8709 and references therein.
(10) (a) Steinmetz, M.; Ueda, K.; Grimme, S.; Yamaguchi, J.;
Kirchberg, S.; Itami, K.; Studer, A. Chem. - Asian J. 2012, 7, 1256−
1260. (b) Nishimoto, Y.; Kondo, H.; Yamaguchi, K.; Yokogawa, D.;
Yamaguchi, J.; Itami, K.; Irle, S. J. Org. Chem. 2017, 82, 4900−4906.
(12) Gilson, R.; Durrant, M. C. Dalton Trans 2009, 10223−10230.
(13) Friestad, G. K.; Branchaud, B. P. Tetrafluoroboronic Acid E-Eros
Encyclopedia of Reagents for Organic Synthesis; Wiley, 2001.
E
Org. Lett. XXXX, XXX, XXX−XXX